MedPath

Assessing effectiveness of PRP and tranexamic acid + vitamne C mesotherapy in the treatment of periorbital dark circle

Phase 2
Conditions
Periorbital hyperpigmentation.
Other melanin hyperpigmentation
L81.4
Registration Number
IRCT20200623047891N2
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Diagnosis of non-structural POH by dermatologist in Afzalipour hospital dermatology clinic
Filling the written letter of satisfaction to participate in the project
Minimum age of 18 when filling the letter of satisfaction
Male or non-pregnant, non-breast feeding female gender

Exclusion Criteria

Smoking
Previous or current bleeding disorders
Using anti coagulant medications
Presence of any active lesion in the treatment area

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of periorbital hyperpigmentation. Timepoint: At the begining of the study (before intervention) and 1 and 3 months after intervention. Method of measurement: Using Patient and Physician Global Assessment score.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath